Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds

Our latest crop of biofinancings features a nine-figure round for #Ambrosia, with #PinnacleMedicines, #Immutrin, and #GilgameshPharma also raising new funds.